Literature DB >> 12853492

The etiologic agent of sarcoidosis: what if there isn't one?

Marc A Judson.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12853492     DOI： 10.1378/chest.124.1.6

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  5 in total

1.  Disturbed homeostasis and multiple signaling defects in the peripheral blood B-cell compartment of patients with severe chronic sarcoidosis.

Authors:  Nam-Sihk Lee; Laura Barber; Shaw M Akula; George Sigounas; Yash P Kataria; Sergio Arce
Journal:  Clin Vaccine Immunol       Date:  2011-06-08

Review 2.  Sarcoidosis: a Critical Review of History and Milestones.

Authors:  Paolo Spagnolo
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

3.  The anergic state in sarcoidosis is associated with diminished dendritic cell function.

Authors:  Sneha Mathew; Kristy L Bauer; Arne Fischoeder; Nina Bhardwaj; Stephen J Oliver
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

4.  Dramatic response to infliximab in refractory neurosarcoidosis.

Authors:  Sreekanth Chintamaneni; Aarat M Patel; Samuel B Pegram; Hirenkumar Patel; Heidi Roppelt
Journal:  Ann Indian Acad Neurol       Date:  2010-07       Impact factor: 1.383

5.  Elevated 1, 25-dihydroxyvitamin D levels are associated with protracted treatment in sarcoidosis.

Authors:  Dashant Kavathia; John D Buckley; Dhanwada Rao; Benjamin Rybicki; Robert Burke
Journal:  Respir Med       Date:  2010-01-13       Impact factor: 3.415
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.